Neurosensum International India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.64 Cr
- Company Age 6 Year, 17 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 85.28%
- Profit Growth -12803.02%
- Ebitda -2689.99%
- Net Worth -190.60%
- Total Assets 593.96%
About Neurosensum International India
Neurosensum International India Private Limited (NIIPL) is a registered startup operating as a Private Limited Foreign Company Incorporated In India incorporated in India on 22 January 2019 (Six years 17 days old ). Its registered office is in Gurgaon, Haryana, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.64 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajiv Lamba and Tanuj Diwan serve as directors at the Company.
Company Details
-
Location
Gurgaon, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72900HR2019FTC078041
-
Company No.
078041
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
22 Jan 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Neurosensum International India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Lamba
|
Director | 22-Jan-2019 | Current |
|
Tanuj Diwan
|
Whole-Time Director | 09-May-2019 | Current |
Financial Performance of Neurosensum International India.
Neurosensum International India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 85.28% increase. The company also saw a substantial fall in profitability, with a 12803.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 190.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neurosensum International India?
In 2023, Neurosensum International India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neurosensum International India?
Neurosensum International India has a workforce of 41 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neurosensum International India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neurosensum International India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
